SUMMARY Neurones containing VIP, substance P, or enkephalin were studied by immunocytochemistry in intestinal specimens from 27 patients with Crohn's disease. Also several endocrine cell systems in the gut were examined. The results were compared with those from a control group of 26 patients. The relative frequency of various endocrine cells did not differ overtly from that in controls. Vasoactive intestinal polypeptide and substance P nerve fibres were distributed in all layers of the gut wall, including the submucosal and myenteric plexuses, whereas enkephalin fibres were. restricted to the smooth muscle layer and the myenteric plexus. The distribution and frequency of the peptide-containing nerve fibres were the same in Crohn's disease patients as in control patients. A proportion of these nerve fibres, however, were notably coarse in the Crohn's disease patients. This was particularly apparent in the afflicted parts of the intestine although it was noted also in non-afflicted parts. The concentration of VIP and substance P (expressed as pmol/g wet weight) did not, however, exceed that of the control group.
Crohn's disease is a chronic form of intestinal inflammation which is segmental, transmural, and granulomatous.l The lesions are predominantly localised to the distal ileum but may engage any part of the gastrointestinal tract.2 As the disease progresses fibrosis develops, causing mural thickening. Stenoses often develop, requiring surgery.3 Pathologists have observed conspicuously coarse intramural nerve fibres both in the submucosal layer and in the smooth muscle4 5 and recently Bishop et a16 in a study of patients with Crohn's disease predominantly localised to the colon reported that nerve fibres containing vasoactive intestinal polypeptide were included among the coarse fibres, and that the VIP concentration in the afflicted parts of the intestine was markedly raised.
In the present study of Crohn's disease patients, most of which had lesions in the ileum, we have examined a variety of intestinal endocrine cell systems and the neuronal systems containing VIP, substance P, or enkephalin. The immunocyto- t Twenty-one patients had carcinoma coli (without signs of inflammatory bowel disease), four had ulcerative colitis (specimens were taken from the ileum only). One patient was subjected to intestinal resection because of suspected tumour. The patients with ulcerative colitis were treated surgically because of suspected malignancy or because of unsuccessful medical treatment. Most lesions were localised to the distal colon leaving colon ascendens unaffected. Fresh specimens were immediately frozen to the temperature of liquid nitrogen in a propane/ propylene mixture and freeze dried. They were then exposed to gaseous diethylpyrocarbonate8 or formaldehyde9 and embedded in paraffin wax in vacuo.
Sections were cut at 5 ,um thickness and placed on albumin coated glass slides. For conventional histology sections were stained with haematoxylineosin and mounted in Permount®. For immunocytochemistry (the PAP technique of Sternbergerl0) the sections were deparaffinised in xylene, hydrated and exposed to peptide or 5-hydroxytryptamine antiserum (Table 3) for 24 hours at 4°C. After rinsing in phosphate buffer, the sections were incubated with unlabelled goat-anti-rabbit IgG (SBL, Stockholm, Sweden) (diluted 1:30) for 30 minutes at room temperature followed by incubation with peroxidase-anti-peroxidase (PAP) complex (diluted 1:160). PAP complex was purchased from Cappel Laboratories, Downington, Pennsylvania, USA. The sections were dehydrated, mounted in Permounts and examined by light microscopy. This protocol can be used to show peptides in endocrine cells. For demonstration of peptides in nerve fibres the specimens were quickly immersed in ice-cold 4% buffered formaldehyde solution (pH 7.2). After fixation overnight the specimens were rinsed repeatedly in buffer containing 5% sucrose, frozen and sectioned at 15 ,um thickness in a cryostat, and processed for the immunocytochemical demons,tration of VIP, substance P, and leu-enkephalin using the indirect immunofluorescence technique." Details of the antisera are given in Table 3 . The sections were exposed to peptide antiserum for three hours at room temperature. After thorough rinsing in phosphate buffer they were incubated with Immunofluorescence (x300, original magnification). 
Results

IMMUNOCYTOCHEMICAL OBSERVATIONS
Endocrine cells The number of 5-hydroxy- Immunofluorescence (x200, original magnification). observed in the submucous and myenteric plexuses.
In non-afflicted smooth muscle of the ileum and in the afflicted colon from subjects with Crohn's disease the number of VIP nerves was lower than in the corresponding locations in control patients (Table 5 ). Coarse VIP nerve fibres were more frequently observed in the afflicted mucosa of the ileum and in the afflicted smooth muscle of the colon than in the corresponding locations in control patients (Table 6 ; Figs 1, 4). Substance P nerve fibres were moderate in number in the ileum and few in the colon. Their frequency was the same in the mucosa as in the smooth muscle. Immunoreactive nerve cell bodies were observed in the submucous and myenteric plexuses in all regions of the intestine. In patients with Crohn's disease the number of substance P fibres did not differ from that in the control group (Table 5 ). In one third of the Crohn's disease patients a large portion of the substance P nerve fibres was graded as coarse in the ileum; in the control group no coarse nerve fibres were observed (Table 6 ; Fig. 2 ).
Enkephalin-containing nerve fibres were more or less restricted to the smooth muscle and the myenteric plexus, where they occurred in a moderate number in the ileum and colon (Table 5 ). Immunoreactive nerve cell bodies were seen in the myenteric plexus. Such nerve cell bodies were more numerous in the non-afflicted than in the afflicted ileum, and more numerous than in the control group. About half of the Crohn's disease patients had coarse nerve fibres in both non-affficted and afflicted ileum; none in the control group had coarse fibres (Table 6 ; Fig. 3 ).
Peptide-containing nerve fibres in the middle part of the ileum in Crohn's disease patients displayed the same frequency and coarseness as those in the distal part. Specimens from Crohn's disease patients previously subjected to intestinal resection did not contain more coarse nerve fibres than those taken from the unresected group with this disease.
IMMUNOCHEMICAL FINDINGS
The concentration of VIP (expressed per gram wet weight) was markedly reduced in the afflicted colon and in some patients also in the non-afflicted colon. In other locations the VIP concentration did not differ significantly from that of the controls. When the VIP concentration was expressed per gram extracted protein no difference was noted between Crohn's disease patients and controls in any location (Table 7 ).
In the afflicted colonic mucosa the substance P concentration was reduced when expressed per gram wet weight whereas no significant difference could be observed when the concentrations were expressed per gram extracted protein (Table 8) .
The concentration of extractable protein in the gut wall of patients with Crohn's disease did not differ significantly from that in the control group (Table 9) .
Discussion
The present immunocytochemical findings indicate that on the whole intestinal nerve fibres containing VIP, substance P, or enkephalin have the same frequency in Crohn's disease patients and in control patients, while being more coarse in Crohn's disease patients. This was particularly apparent in the afflicted parts of the intestine although it was noted also in non-afflicted parts. In the ileum all three types of peptide containing nerve fibres were coarse, whereas in the colon only VIP nerve fibres were coarse. On the whole our morphological findings confirm and extend those of Bishop et al. 6 These authors, however, reported much higher VIP concentration (expressed as pmol/g wet weight) in the intestine of patients with Crohn's disease than in control patients, a finding that we have not been able to confirm. In our study, the concentration of VIP in the intestine of Crohn's disease patients did not exceed that of the control group. On the contrary, the VIP concentration in the afflicted colon was reduced. As Crohn's disease is associated with increased thickness of the bowel wall because of fibrosis and oedema, however, the unchanged VIP and substance P concentrations in the intestine in Crohn's disease patients may correspond to an increased total amount of intestinal VIP and substance P. It must be realised that the patients of the present study differ from the patients described by Bishop et a)6 in that the lesions were localised to the ileum rather than to the colon. The two groups of patients may differ also with respect to the severity of the lesions. Crohn's disease seems to affect several types of peptide containing nerves such as those containing VIP, substance P, or enkephalin. As chemical determinations did not reveal any increase in the intestinal VIP and substance P concentrations compared with the control group the changes are probably less pronounced than suggested from previous observations.6
The mechanisms behind the neuromorphological changes in Crohn's disease are obscure. They may be secondary to the intestinal inflammation and fibrosis.
